FDA Approves CRC Screening Test for Younger, At-Risk Individuals

Sep 23, 2019 – The FDA has expanded the approval of the noninvasive colorectal cancer (CRC) screening test Cologuard to include eligible at-risk individuals ≥45 years. The updated indication of the at-home stool-based screening assay applies to approximately 19 million average-risk individuals in the United States between the ages of 45 to 49. Cologuard was previously indicated for those ≥50 years. “About 3 million people have been screened for colorectal … (leggi tutto)